Skip to main content
. Author manuscript; available in PMC: 2017 Dec 11.
Published in final edited form as: Nat Biotechnol. 2017 Jun 7;35(6):530–542. doi: 10.1038/nbt.3889

Figure 1.

Figure 1

The true lifesaving potential of organ transplantation. The roughly 50,000 US patients added to transplant waiting lists in 2011 were outnumbered over 14-fold by those who died from end-stage organ disease (http://www.perfusix.com/impact-of-ex-vivo.html), without counting cases where malignancies could have been treated with organ replacement168. This suggests that the true size of the organ shortage could be many times larger than is reflected by transplant waiting lists (currently 120,000 US patients).